- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07587190
Effectiveness of Implementing the Adapted Practice Guidelines for Primary Care of Acute Abdomen in Zambia: An Effectiveness-Implementation Hybrid Type 2 Study Design.
May 8, 2026 updated by: University of Bergen
The study aims 1) to adapt, 2) to develop implementation strategies for and 3) to evaluate the effect of implementing a practice guideline for acute abdomen at primary care level in Zambia.
We employ a sequential exploratory mixed method study design.
Qualitative and quantitative data from health care workers will be used to adapt a practice guideline developed in a high-income into a low- and middle-income (LMIC) context and to develop strategies for successful implementation.
The primary outcome of interest is the prospective change in length of stay in hospital among patients presenting with acute abdomen in the intervention site compared to the control site.
The study will address the scarcity of literature on practice guidelines for acute abdomen in the LMIC context.
The implementation of an adapted guideline may contribute to a reduction of the morbidity and mortality rates associated with acute abdomen in this setting by increasing management capacity at the primary care level.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
280
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Wilson Mbewe, MD
- Phone Number: +260977466316
- Email: wimbe8573@uib.no
Study Locations
-
-
Lusaka Province
-
Lusaka, Lusaka Province, Zambia, 10101
- Recruiting
- Kanyama First Level Hospital and Matero First Level Hospital
-
Contact:
- Nalukuyi Wanga
- Phone Number: +26097503805
- Email: nalu07@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Data from all patients 18 year and older with acute abdomen including surgical, gynecological and medical acute abdomen managed at the intervention site and control site will be collected during the study period.
Exclusion Criteria:
- All cases of acute abdomen secondary to trauma will be excluded from the study. All patients in the immediate postoperative phase operated from other facilities presenting with acute abdomen.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention site
The intervention site will have the guidelines for acute abdomen implemented
|
Adjusted practice guidelines for primary care of acute abdomen will be implemented at the intervention site.
|
|
Active Comparator: Control site
The control site will not have the guidelines implemented
|
The control site will receive no intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of Hospital Stay
Time Frame: 7 days
|
The duration of time in days that a patient with acute abdomen stays in the hospital from the day of admission to discharge
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Elisabeth Marie Strømme, MD, PhD, University of Bergen
- Study Director: Thomas Mildestvedt, MD, PhD, University of Bergen
- Study Director: Eivind Meland, University of Bergen
- Study Director: Mpundu Makasa, University of Zambia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2025
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
December 31, 2028
Study Registration Dates
First Submitted
May 8, 2026
First Submitted That Met QC Criteria
May 8, 2026
First Posted (Actual)
May 14, 2026
Study Record Updates
Last Update Posted (Actual)
May 14, 2026
Last Update Submitted That Met QC Criteria
May 8, 2026
Last Verified
August 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Signs and Symptoms, Digestive
- Abdominal Pain
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Abdomen, Acute
- Health Services Administration
- Health Care Quality, Access, and Evaluation
- Quality of Health Care
- Guidelines as Topic
- Quality Assurance, Health Care
- Practice Guidelines as Topic
Other Study ID Numbers
- REK Ref No: 576758
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.